Product Benefits

• Balanced Dual Action: Offers the combined efficacy of Salmeterol (a long-acting agent that keeps air passages open) and Fluticasone (a corticosteroid that reduces chronic inflammation), providing 12-hour protection against symptom recurrence.

• Mid-Range Steroid Dosing: The $125\text{mcg}$ dose of Fluticasone Propionate provides effective anti-inflammatory control suitable for patients with moderate persistent asthma who need more than a low-dose steroid but may not require the highest dose.

• Sustained Symptom Relief: Regular, twice-daily use provides continuous control over symptoms like wheezing, chest tightness, and coughing, significantly improving the patient's breathing capacity and overall lung health.

• Exacerbation Prevention: A core function of the combination is to reduce the frequency and severity of asthma and COPD flare-ups, leading to fewer sick days and emergency medical needs.

• Improved Quality of Life: By stabilizing lung function and reducing chronic symptoms, the inhaler enables patients with chronic respiratory conditions to engage more fully in daily and physical activities.